Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Caring Brands, Inc.

Ticker
CABR
Sector
Industry
Report date
November 13, 2026
Valye AI Score

84

Very high visibility
Recent developments
Recent developments summary

Recent developments include capital raises through private placements, intellectual property updates with new patents, expanded licensing agreements, and Nasdaq uplisting.

Recent developments:
  • Caring Brands completed an initial $4.6 million closing under an ongoing $9 million private placement as of September 2026 [N1].
  • The company provided an update on its intellectual property portfolio in August 2026, highlighting patent activity and portfolio strength [N2].
  • Caring Brands and SanPellegrino Cosmetics Private Limited announced an expanded multi-territory licensing agreement for Photocil and Hair Enzyme Booster in June 2026 [N3].
  • The company secured two new U.S. patents strengthening Hair Enzyme Booster technology as of February 2026 [N4].
  • Caring Brands announced an exclusive global license to manufacture and market Emesyl in January 2026 [N5].
  • The company closed a $4 million uplisting to Nasdaq in November 2025 [N6].
  • Pricing of the $4 million uplisting to Nasdaq was announced in November 2025 [N7].
Overview

Caring Brands operates in the wellness consumer products sector with a diverse product pipeline including Photocil for vitiligo and psoriasis, Hair Enzyme Booster (JW-700) for enhancing minoxidil efficacy in hair loss treatment, CB-101 for eczema, and NoStingz sunscreen with jellyfish sting protection. The company markets products primarily in India and the US, with licensing agreements covering multiple international territories. Products are developed with clinical trial support and protected by patents. The company has recently completed capital raises and Nasdaq uplisting to support growth and commercialization efforts.

Executive summary

Caring Brands, Inc. is a wellness consumer products company focused on OTC and cosmetic products addressing conditions such as hair loss, eczema, psoriasis, vitiligo, and sun protection. The company emphasizes clinical validation, patent protection, and regulatory compliance for its products. Recent developments include securing patents, expanding licensing agreements, and raising capital through private placements and Nasdaq uplisting. Financially, the company reported nominal revenues and a net loss for the recent periods but maintains strong liquidity as of September 30, 2026. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.

Scenarios for CABR

Bull case model:

The company has established a diversified product pipeline with clinical validation and patent protection, positioning it to capitalize on growing wellness markets such as phototherapy for skin conditions and hair loss treatments. Recent capital raises and Nasdaq uplisting provide financial resources to support commercialization and marketing efforts. Expanded licensing agreements across multiple territories could enable broader market penetration and revenue growth.

Bear case model:

Caring Brands faces challenges including nominal current revenues, ongoing net losses, and reliance on successful commercialization and marketing execution. Market adoption of products like Photocil in the US has been limited due to lack of dedicated sales teams. Regulatory and competitive risks remain, and there is uncertainty regarding the timing and success of product relaunches and reformulations. The company’s financial sustainability depends on continued capital raises and effective execution.

Moat:

Caring Brands' moat is built on its portfolio of patented wellness products supported by clinical trials, regulatory compliance, and exclusive licensing agreements with regional partners. Its Hair Enzyme Booster technology has multiple granted and pending patents, and Photocil's unique narrow band UV filter formulation differentiates it in the phototherapy market. The company's strategic licensing partnerships and intellectual property portfolio provide barriers to entry and potential for market expansion.

Risks overview
Risks summary
The primary risks for Caring Brands relate to successful commercialization and market adoption of its products amid regulatory requirements and financial constraints.
Risks details:

• Commercialization Risk: Limited sales history and prior removal of Photocil from the US market due to insufficient sales highlight risks in market adoption and the need for dedicated sales and marketing resources.
• Regulatory and Compliance Risk: Products require compliance with FDA and USP monographs, and some require FDA registration and NDC numbers prior to marketing, which may delay commercialization.
• Financial Risk: The company has reported net losses and nominal revenues, relying on capital raises and private placements to fund operations, which may dilute existing shareholders.
• Market Competition: The wellness and phototherapy markets are competitive with alternative treatments and products, which may limit market penetration and pricing power.

FINAL FORECAST FOR CABR

Final take one line
Caring Brands, Inc. exhibits very high visibility with a well-documented wellness product pipeline, patent-backed technologies, and recent capital and licensing developments supporting its commercialization efforts.
Final take 12 to 24 month view

Business trends: Expansion of product portfolio in wellness and phototherapy markets with clinical validation and patent protection; growing licensing agreements across multiple territories.
Execution milestones: Completion of private placements and Nasdaq uplisting; securing new patents; planned product relaunches and reformulations.
Key risks: Commercialization challenges including market adoption and sales execution; regulatory compliance and approval requirements; financial sustainability amid ongoing losses and capital needs.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

84
LLM visibility overview
LLM Visibility known facts
  • Caring Brands, Inc. is a wellness consumer products company offering over-the-counter (OTC) and cosmetic consumer products focused on health and wellness needs including hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, jellyfish sting protective suncare, and women's sexual wellness products [S1].
  • The company ensures its products have established mechanisms of action, efficacy through controlled clinical trials, patent protection, and commercial stability [S1].
  • Photocil is a narrow band UV filter product for vitiligo and psoriasis treatment, launched commercially in India in Q3 2022 and briefly in the US from Dec 2022 to Feb 2023 but removed due to insufficient sales and lack of a dedicated sales and marketing team. A US relaunch is targeted for 2026 with no formulation changes planned [S1].
  • Photocil is marketed as an OTC cosmetic product in India compliant with local regulations and previously had FDA-registered labeling in the US. It uses USP monographed ingredients and does not require FDA pre-market approval [S1].
  • The Hair Enzyme Booster (JW-700) is a cosmetic product designed to enhance minoxidil efficacy by increasing sulfotransferase enzyme levels. It is marketed in India and the US, launched on Amazon in the US in Q4 2024, and has 2 granted and 5 pending patents [S1].
  • CB-101 is an OTC topical treatment for atopic dermatitis (eczema) undergoing reformulation with plans for US online availability in 2026 as an OTC product under a USP monograph [S1].
  • NoStingz is a planned reformulated sunscreen product designed to protect against UV rays and jellyfish stings, intended to comply with FDA sunscreen guidelines and require FDA registration prior to marketing [S1].
  • The company has licensing agreements with Cosmofix and San Pellegrino Cosmetics for marketing and manufacturing Photocil and Hair Enzyme Booster in India and multiple other territories, with ongoing exploration of sublicensing opportunities in Asia, Africa, Europe, and South America [S1][N3].
  • Caring Brands has an exclusive global license to manufacture and market Emesyl [N5].
  • The company completed an initial $4.6 million closing under an ongoing $9 million private placement as of September 2026 [N1].
  • Caring Brands secured two new U.S. patents strengthening Hair Enzyme Booster technology as of February 2026 [N4].
  • The company uplisted to Nasdaq with a $4 million financing closing in November 2025 [N6][N7].
  • As of September 30, 2026, the company had $7.67 million in cash and equivalents, current assets of $8.31 million, current liabilities of $0.51 million, resulting in a current ratio of 16.32 and a cash ratio of 15.05, indicating strong liquidity [S2].
  • The company reported a net loss of $700,978 for the nine months ended September 30, 2026, and basic and diluted EPS of -$0.08 for the same period [S2].
  • Revenue was nominal at $4,215 for the year ended December 31, 2025 [S2].
Sources
Sources - Context summary

Generated 2026-11-13

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-31 | 10-K
  • S2 | 2026-11-13 | 10-Q
Sources - News headlines
  • N1 | 2026-09-02 | www.nasdaq.com | Caring Brands Inc. (Nasdaq: CABR) Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement | https://www.nasdaq.com/press-release/caring-brands-inc-nasdaq-cabr-completes-initial-46-million-closing-under-ongoing-9
  • N2 | 2026-08-06 | www.nasdaq.com | Caring Brands Provides Intellectual Property Portfolio Update | https://www.nasdaq.com/press-release/caring-brands-provides-intellectual-property-portfolio-update-2026-08-06
  • N3 | 2026-06-01 | www.nasdaq.com | Caring Brands Inc. and SanPellegrino Cosmetics Private Limited Announce Expanded Multi-Territory Licensing Agreement for Photocil and Hair Enzyme Booster | https://www.nasdaq.com/press-release/caring-brands-inc-and-sanpellegrino-cosmetics-private-limited-announce-expanded-multi
  • N4 | 2026-02-03 | www.nasdaq.com | Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology | https://www.nasdaq.com/press-release/caring-brands-secures-two-new-us-patents-strengthening-hair-enzyme-booster-technology
  • N5 | 2026-01-05 | www.nasdaq.com | Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl | https://www.nasdaq.com/press-release/caring-brands-announces-exclusive-global-license-manufacture-and-market-emesyl-2026
  • N6 | 2025-11-14 | www.nasdaq.com | Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq | https://www.nasdaq.com/press-release/caring-brands-announces-closing-4000000-million-uplisting-nasdaq-2025-11-14
  • N7 | 2025-11-13 | www.nasdaq.com | Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq | https://www.nasdaq.com/press-release/caring-brands-announces-pricing-4000000-million-uplisting-nasdaq-2025-11-13
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine